Virginia Rybski appointed to the AdvaMed Board of Directors. Ms. Rybski serves as Scotsdale, Arizona based Regenesis’ President and Chief Executive Officer.
Regenesis Biomedical, Inc., a medical technology company focused on regenerative medicine, announces that Virginia Rybski was appointed to the AdvaMed Board of Directors. Ms. Rybski serves as Regenesis President and Chief Executive Officer.
AdvaMed is the Advanced Medical Technology Association, whose member companies produce medical devices, diagnostic products, and health information systems. AdvaMed advocates for a legal, regulatory and economic environment that advances global health care.
For the past two years, Ms. Rybski has served on the competitive bidding workgroup, payment and health care delivery committee, and the advanced wound management sector workgroup.
“I am pleased to further my involvement in the AdvaMed mission of increasing patient access to the benefits of medical technology,” said Virginia Rybski, President and CEO of Regenesis. “A core value of Regenesis’ is having compassion, especially for patients in need.”
About Regenesis Biomedical
Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant Therapy System. Our customers include health care facilities, acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.
About the Provant® Therapy System
Provant uses pulsed radio frequency energy (PRFE) to facilitate reduction of the pain and edema associated with post-operative, superficial soft tissues.
Contact: Regenesis Biomedical, Inc.
Scott Robey, Vice President Marketing
480-970-4970
SOURCE: Regenesis Biomedical Inc.
AdvaMed Appoints Regenesis Biomedical Chief Executive to Board of Directors
Furthers involvement in increasing patient access to medical technology
Scottsdale, Arizona, March 8, 2011 — Regenesis Biomedical, Inc., a medical technology company focused on regenerative medicine, announces that Virginia Rybski was appointed to the AdvaMed Board of Directors. Ms. Rybski serves as Regenesis President and Chief Executive Officer.
AdvaMed is the Advanced Medical Technology Association, whose member companies produce medical devices, diagnostic products, and health information systems. AdvaMed advocates for a legal, regulatory and economic environment that advances global health care.
For the past two years, Ms. Rybski has served on the competitive bidding workgroup, payment and health care delivery committee, and the advanced wound management sector workgroup.
“I am pleased to further my involvement in the AdvaMed mission of increasing patient access to the benefits of medical technology,” said Virginia Rybski, President and CEO of Regenesis. “A core value of Regenesis’ is having compassion, especially for patients in need.”
About Regenesis Biomedical
Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant Therapy System. Our customers include health care facilities, acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.
About the Provant® Therapy System
Provant uses pulsed radio frequency energy (PRFE) to facilitate reduction of the pain and edema associated with post-operative, superficial soft tissues.
Contact: Regenesis Biomedical, Inc.
Scott Robey, Vice President Marketing
www.regenesisbio.com
480-970-4970
SOURCE: Regenesis Biomedical Inc.
Read more at … AdvaMed Appoints Regenesis Biomedical Chief Executive to Board of Directors